Femsa Health
Femsa Health, a prominent division of Fomento Económico Mexicano, S.A.B. de C.V., is headquartered in Mexico (MX) and operates extensively across Latin America. Founded in 1890, Femsa has evolved into a leader in the healthcare industry, focusing on pharmaceutical distribution and retail services. The company is renowned for its innovative approach to health solutions, offering a diverse range of products and services that cater to the needs of both consumers and healthcare professionals. Femsa Health's commitment to quality and accessibility has positioned it as a trusted name in the market, with notable achievements in expanding its operational footprint and enhancing customer experience. With a strong emphasis on community health and wellness, Femsa Health continues to set benchmarks in the industry, making significant strides in improving healthcare delivery across its major operational regions.
DitchCarbon Score
How does Femsa Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Femsa Health's score of 41 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Femsa Health's reported carbon emissions
In 2024, Femsa Health reported total carbon emissions of approximately 1,003,012,000 kg CO2e for Scope 1 and 444,618,000 kg CO2e for Scope 2 (market-based), resulting in a combined total of about 1,447,630,000 kg CO2e for both scopes. In 2023, the emissions were slightly higher, with Scope 1 at approximately 1,017,510,000 kg CO2e and Scope 2 (market-based) at about 457,180,000 kg CO2e, leading to a total of around 1,474,689,000 kg CO2e. Femsa Health has not disclosed any Scope 3 emissions data, indicating a focus on direct and indirect emissions from their operations. The company has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, suggesting a need for further commitment in this area. Over the years, Femsa Health has shown a trend of emissions intensity improvement, with emissions intensity reported at 0.0027 tonnes CO2e per million USD in sales for 2024, down from 0.0025 in 2023 and 0.0021 in 2022. This indicates a gradual reduction in emissions relative to revenue, reflecting efforts to enhance operational efficiency. Overall, while Femsa Health has made strides in emissions management, the absence of formal reduction targets and Scope 3 emissions data highlights opportunities for further climate action and transparency in their sustainability commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 1,133,191,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 406,258,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Femsa Health is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
